Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer. Academic Article uri icon

Overview

publication date

  • February 1, 2000

Research

keywords

  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Oligopeptides

Identity

Scopus Document Identifier

  • 0034093431

PubMed ID

  • 10761761

Additional Document Info

volume

  • 11

issue

  • 2